One scientist may have cracked the code to curing Alzheimer’s and Parkinson’s—using a single molecular switch.

Scientific research has traditionally been a slow and careful process. Scientists spend years testing ideas and doing ...

AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...

Quantum-enhanced drug discovery emerges as a leading investment trend within the pharmaceutical sector for 2025. Since the ...

Collaboration combines Nuclera's eProtein Discovery System, which accelerates protein expression, purification and ...

Microsoft Scientific Discovery is an AI-powered research-focused platform designed for scientists, research institutions, and ...

Colorado BioScience Association (CBSA) commends the Colorado Office of Economic Development and International Trade (OEDIT) for awarding $3.135 Million in Commercialization Infrastructure grants under ...

Collaboration combines Nuclera’s eProtein Discovery System with Cytiva’s Biacore SPR system.

Biopharma Industry Landscape Report—uncover key trends in obesity, oncology, immunology, and AI, plus top stock picks and ...

Machine learning and supercomputing have brought about a revolution in computational drug discovery. More therapeutic candidates, like antibodies that bind to and fight the SARS-CoV-2 virus, can be ...

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid ...

Despite significant advances in cancer diagnosis and treatment, tumor recurrence, metastasis, and drug resistance remain major clinical challenges. These ...